Benjamin D. Hedley Special Hematology/Flow Cytometry London Health Sciences Centre Biography Publications Institution JoVE Articles Benjamin D. Hedley has not added a biography. If you are Benjamin D. Hedley and would like to personalize this page please email our Author Liaison for assistance. Publications Determination of Optimal Replicate Number for Validation of Imprecision Using Fluorescence Cell-based Assays: Proposed Practical Method Cytometry. Part B, Clinical Cytometry. Sep, 2013 | Pubmed ID: 24022856 Determination of Optimal Replicate Number for Validation of Imprecision Using Fluorescence Cell Based Assays: Proposed Practical Method Cytometry. Part B, Clinical Cytometry. Jul, 2013 | Pubmed ID: 23873644 Response to Rossi Et Al Cytometry. Part A : the Journal of the International Society for Analytical Cytology. Jul, 2013 | Pubmed ID: 23788417 User-defined Protein Marker Assay Development for Characterization of Circulating Tumor Cells Using the CellSearch® System Cytometry. Part A : the Journal of the International Society for Analytical Cytology. Nov, 2012 | Pubmed ID: 22899576 Recombinant Human Erythropoietin in Combination with Chemotherapy Increases Breast Cancer Metastasis in Preclinical Mouse Models Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2011 | Pubmed ID: 21856770 The Role of Erythropoietin and Erythropoiesis-stimulating Agents in Tumor Progression Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2011 | Pubmed ID: 21750199 The Synthetic Triterpenoid CDDO-Imidazolide Suppresses Experimental Liver Metastasis Clinical & Experimental Metastasis. Mar, 2011 | Pubmed ID: 21234655 Tumor Dormancy and Metastasis Advances in Cancer Research. 2009 | Pubmed ID: 19595307 High Aldehyde Dehydrogenase and Expression of Cancer Stem Cell Markers Selects for Breast Cancer Cells with Enhanced Malignant and Metastatic Ability Journal of Cellular and Molecular Medicine. Aug, 2009 | Pubmed ID: 18681906 BRMS1 Suppresses Breast Cancer Metastasis in Multiple Experimental Models of Metastasis by Reducing Solitary Cell Survival and Inhibiting Growth Initiation Clinical & Experimental Metastasis. 2008 | Pubmed ID: 18543067 Downregulation of Osteopontin Contributes to Metastasis Suppression by Breast Cancer Metastasis Suppressor 1 International Journal of Cancer. Journal International Du Cancer. Aug, 2008 | Pubmed ID: 18470911 The Thrombin Inhibitor Argatroban Reduces Breast Cancer Malignancy and Metastasis Via Osteopontin-dependent and Osteopontin-independent Mechanisms Breast Cancer Research and Treatment. Nov, 2008 | Pubmed ID: 18097747 Tumor Dormancy and the Role of Metastasis Suppressor Genes in Regulating Ectopic Growth Future Oncology (London, England). Oct, 2006 | Pubmed ID: 17026454 Therapeutic Targets for Antimetastatic Therapy Expert Opinion on Therapeutic Targets. Dec, 2004 | Pubmed ID: 15584860 Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications Lori E. Lowes1,2, Benjamin D. Hedley3, Michael Keeney3,4, Alison L. Allan1,2,4,5 1London Regional Cancer Program, London Health Sciences Centre, 2Department of Anatomy & Cell Biology, Schulich School of Medicine and Dentistry, Western University, 3Special Hematology/Flow Cytometry, London Health Sciences Centre, 4Lawson Health Research Institute, 5Department of Oncology, Western University JoVE 51248 Médecine
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications Lori E. Lowes1,2, Benjamin D. Hedley3, Michael Keeney3,4, Alison L. Allan1,2,4,5 1London Regional Cancer Program, London Health Sciences Centre, 2Department of Anatomy & Cell Biology, Schulich School of Medicine and Dentistry, Western University, 3Special Hematology/Flow Cytometry, London Health Sciences Centre, 4Lawson Health Research Institute, 5Department of Oncology, Western University JoVE 51248 Médecine